The Truth About GLP-1s
The Impact of Weight Loss Drugs on the Food and Drink Industry
As the popularity of GLP-1 weight loss drugs such as Ozempic and Wegovy continues to grow, many in the food, drink, and lifestyle industries are grappling with the implications these medications have on consumer behaviour and product demand.
Hamish Renton explores the real impact of these drugs, which are known for suppressing appetite and altering eating habits, breaking down the hidden truths behind their rapid rise and the side effects that accompany their use. He also looks at how these changes in consumer behaviour are influencing food consumption, retail, and foodservice industries.
Watch here:
Key Takeaways:
GLP-1s are changing the way consumers engage with food, with some users reporting reduced desire to eat and even diminished enjoyment of food.
Side effects like nausea, lethargy and pancreatitis are raising concerns about the long-term viability of these drugs as a quick-fix solution.
These medications are also affecting the alcohol and food sectors, with many users experiencing lower tolerance for alcohol and less demand for larger portion sizes.
As more people turn to these medications, food brands, retailers, and even the hospitality sector will need to adapt to meet changing demands. Staying ahead of these shifts will be crucial for businesses looking to thrive in an increasingly health-conscious market.
